Sign in

CIK 0001846253

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

OmniAb, Inc.

Sign in to watch
Ticker
OABI
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 510-250-7800
Business address
5980 HORTON STREET, SUITE 600, EMERYVILLE, CA, 94608
Former names
Avista Public Acquisition Corp. II

Securities

  • OABI Common Stock Nasdaq
  • OABIW Warrant Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-06-18 Boyce Sarah Director Exercise or conversion +20,000 68,381
2024-06-18 Boyce Sarah Director Exercise or conversion · Restricted Stock Units −20,000 0
2024-06-18 Boyce Sarah Director Grant or award · Restricted Stock Units +20,000 20,000
2024-06-18 Boyce Sarah Director Grant or award · Stock Option (right to buy) +40,000 40,000
2023-06-23 Boyce Sarah Director Grant or award · Restricted Stock Units +20,000 20,000
2023-06-23 Boyce Sarah Director Grant or award · Stock Option (right to buy) +40,000 40,000
2023-01-30 Boyce Sarah Director Grant or award +8,753 46,190
2023-01-30 Boyce Sarah Director Grant or award · Stock Option +37,840 37,840
2022-11-10 Boyce Sarah Director Purchase +15,000 $2.92 $44K 36,000
2022-11-09 Boyce Sarah Director Purchase +21,000 $2.74 $58K 21,000
2022-11-01 Boyce Sarah Director Grant or award +39,628 48,381
2022-11-01 Boyce Sarah Director Grant or award +37,437 37,437
2022-11-01 Boyce Sarah Director Grant or award · Stock Option +22,616 22,616
2022-11-01 Boyce Sarah Director Grant or award · Stock Option +10,565 10,565
2022-11-01 Boyce Sarah Director Grant or award · Stock Option +13,994 13,994
2022-11-01 Boyce Sarah Director Grant or award · Stock Option +37,840 37,840

Page 1 of 1 · 16 trades